US EditionSuven Pharmaceuticals Announces May 1, 2025 as Effective Date for Amalgamation of Cohance Lifesciences - Business News Week
Summary by businessnewsweek.in
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Suven Pharmaceuticals Announces May 1, 2025 as Effective Date for Amalgamation of Cohance Lifesciences - Business News Week
Mumbai/Hyderabad, April 26, 2025: Suven Pharmaceuticals Limited (BSE: 543064, NSE: SUVENPHAR), a leading contract development and manufacturing organization (CDMO), announced that it has received final approval from the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Government of India, for foreign investment under applicable regulations. This marks the final regulatory clearance required to implement the Scheme of A…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
